Two Hospitals In Gujarat Suspended Over Misuse Of PM-JAY Scheme

Ahmedabad:  Following the Khyati hospital controversy, more cases of misuse of the PM-JAY scheme have come to light in Gujarat. Two more hospitals of the state were suspended over this and a total fine of Rs 3.18 crore has been imposed on them.

The Health Department has started an investigation into hospitals under the PM-JAY scheme. During the investigation, irregularities were found at Krishna Surgical Hospital and Swastik Multi-Specialty Hospital in Rajkot. Additionally, several irregularities were found at Jayaben Modi Hospital in Bharuch and Bankers Super Specialty Hospital in Vadodara.

When the Swastik Multi-Specialty Hospital in Rajkot was investigated, it was revealed that 196 sonography reports had been tampered. As a result, the hospital was suspended from the scheme, and a fine of Rs 2.94 crore was imposed.

Krishna Surgical Hospital in Rajkot was suspended for not having the required building permission and staff. Due to these deficiencies, the hospital was suspended.

In Bharuch, Jayaben Modi Hospital was found to have falsified tumor board certificates by using incorrect signatures and seals, which were then uploaded into the software. As a result, the hospital management has been asked to repay Rs 33,44,031.

At Bankers Super Specialty Hospital in Vadodara, violations of PM-JAY scheme guidelines in oncology surgery were found. A recovery of Rs 57,51,689 will be made from the hospital.

The State Anti-Fraud Unit has intensified its investigations to stop irregularities in private hospitals across Gujarat. Given the ongoing investigations, there is a possibility of further scandals being exposed in the coming days.

Related Posts

NHS backs delayed‑release treatment for cystinosis

Decision expands options for eligible patients NHS England has recommended delayed‑release mercaptamine bitartrate for routine commissioning for eligible patients aged one year and above with nephropathic cystinosis. The decision provides…

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Mumbai/Pune: In a major regulatory enforcement action aimed at safeguarding public health, the Maharashtra Food and Drug Administration (FDA) has permanently cancelled the Ayurvedic drug manufacturing licence of Pune-based M/s Inducare Pharma…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

NHS backs delayed‑release treatment for cystinosis

NHS backs delayed‑release treatment for cystinosis

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Promotion of Drug Inspectors (Medical Devices) raises hopes of Effective Regulation & Patient Safety

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Maharashtra FDA Permanently Cancels Licence of Pune Ayurvedic Drug Manufacturer Over Serious GMP and Quality Violations

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Telangana DCA Seizes Gabapentin Tablets Falsely Sold as Nutraceuticals in Hyderabad

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

Massive Blood Wastage in Gujarat: Over 85,000 Units Discarded Due to Storage Lapses and Expiry

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care

AmeriHealth Home Healthcare Celebrates 5 Years of Compassionate Care